Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
C4 Therapeutics, Inc. (CCCC) had Book Value Per Share of $2.01 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$6.64M |
|
$-23.64M |
|
-- |
|
$6.64M |
|
$33.06M |
|
$-26.42M |
|
$2.79M |
|
$-23.64M |
|
$-23.64M |
|
$-23.64M |
|
$-23.64M |
|
$-23.64M |
|
$-23.64M |
|
$-26.42M |
|
$-26.32M |
|
130.70M |
|
130.70M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$262.90M |
|
$4.15M |
|
$96.50M |
|
$359.40M |
|
$48.25M |
|
-- |
|
$63.89M |
|
$112.14M |
|
$247.26M |
|
$247.26M |
|
$247.26M |
|
122.91M |
|
| Cash Flow Statement Financials | |
$-31.52M |
|
$1.34M |
|
$34.19M |
|
$78.05M |
|
$82.05M |
|
$4.01M |
|
$5.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-397.88% |
|
-397.88% |
|
-- |
|
-355.90% |
|
-355.90% |
|
$-31.62M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
4.98 |
|
18.08 |
|
-9.56% |
|
-9.56% |
|
-6.58% |
|
-9.56% |
|
|
Book Value Per Share |
$2.01 |
$-0.24 |
|
$-0.24 |
|